The GAPS explanation of demyelinating disease connects the gut wall, the immune system, exposure to toxins and the materials needed to repair myelin. Dr. Natasha Campbell-McBride develops this account in the myelin entry of her 2020 book.[1]
Following the explanation in order makes it easier to see what each part is doing. Gut-barrier damage, an antibody result, a bacterial association and a neurological diagnosis are different kinds of information. You can understand how the author connects them without treating them as the same test result.
The Gut-Wall and Immune Connection
Campbell-McBride describes abnormal gut flora damaging the gut wall, with improperly digested food and microbial or environmental toxins passing into the body. She connects this with systemic inflammation, autoimmunity and impaired detoxification. In her account, restoring the gut barrier reduces that continuing load and allows the body to begin repairing damaged tissues.[1]
This is why her nutritional recommendation is more than removing one food. It combines nourishment, changes to gut flora and the wider GAPS protocol. The overview explains the different conditions she discusses together, while the food guide handles the actual starting route.
Why Fatty Myelin Features in the Explanation
Myelin is made from repeated layers of cell membrane. The book proposes that fat-soluble toxins and metals can accumulate in these membranes, alter proteins and make the tissue a target for inflammatory and autoimmune activity. As the covering is injured, the nerve fiber underneath becomes vulnerable too.[1]
The source also reports that people with GAPS conditions can have antibodies against myelin that overlap with those seen in MS. That is Campbell-McBride’s clinical account. An antibody result needs its own test name and interpretation; the overlap does not by itself establish an MS diagnosis.[2]
What the Microbiome Research Examined
The book cites the 2018 review The Gut Microbiome and Multiple Sclerosis. It discusses gut microbes in immune regulation, intestinal and blood–brain barriers, animal models and early human research. The review proposes the microbiome as an important environmental influence and a possible therapeutic target.[3]
One underlying study compared 71 untreated relapsing-remitting MS patients with 71 healthy controls. It found differences in particular bacterial groups, including increased Akkermansia and Acinetobacter. The investigators then examined immune-cell responses and transferred patient or control microbiota into mice. Patient-derived microbiota worsened the experimental disease in that model.[4]
This is a useful connection between a human microbial pattern and experimental immune effects. The study tested bacterial extracts and mouse models; it did not test GAPS or show that every person with MS has one bacterial cause. Its value here is the specific gut–immune link it investigated.[4]
Infections, Metals and Other Proposed Influences
The 2020 entry discusses research and reports involving Clostridium perfringens, Epstein–Barr virus, human herpesvirus 6, endogenous retroviruses, Borrelia and Chlamydophila pneumoniae. It also discusses immune responses involving heat-shock proteins and a 2016 lecture by Alan MacDonald reporting worm findings. These are separate lines of inquiry in the source, not one infection panel or evidence that every patient carries every organism.[1]
The environmental-toxin review cited by the book surveys possible influences from metals, solvents, microbes, drugs and other exposures. It brings together different study designs and experimental settings. That helps explain why exposure belongs in a history, while leaving the cause of an individual’s condition to its own assessment.[5]
If you have an old laboratory result or a dental-treatment record, keep the original document. A symptom does not identify a metal, and the fact that a microbe appears in a research discussion is not a reason to begin antimicrobial or parasite treatment.
Cholesterol, Repair and Medicines
Campbell-McBride emphasizes cholesterol and saturated fats as structural materials for myelin and repair. Her cholesterol chapter connects cholesterol synthesis with myelin synthesis and discusses concerns about cholesterol-lowering medicines. The food recommendation follows from that nutritional explanation.[1][2]
For the wider source discussion, read cholesterol and GAPS food sources and the book’s statin discussion. Keep the actual prescription and the reason it was prescribed with your clinician; this article does not direct a medicine change.
Genes and the CMT FAQ
The CMT answer uses epigenetics to explain why Campbell-McBride recommends changing the internal nutritional environment even when a condition is genetic. It reports peripheral-neuropathy recoveries, but gives no CMT subtype, genetic test result or inherited-mutation outcome for those cases.[6]
CMT includes different genetic forms affecting the axon, myelin or both. A nutritional explanation does not remove the need to keep that subtype distinct. The appointment-note guide includes a place for the actual diagnosis and testing already completed.[7]
Make the Explanation Useful in Daily Life
| Question You Are Reading About | A Useful Detail to Bring |
|---|---|
| Gut symptoms | What changed, when it began and which foods or preparations were involved. |
| A test result | The original report, date and the explanation you were given. |
| Heat sensitivity | What became worse, the setting and how long it lasted. |
| Nutrition and treatment | Your current food phase, medicine list and the exact supplement labels. |
You do not have to solve the whole explanation before asking a good question. My Care Team Log is intended to keep reports, observations and questions together. A dated notebook works now; begin with the issue that most affects your day.
References
- Campbell-McBride, N. Gut and Physiology Syndrome (2020), A–Z, Myelin and demyelinating disease.
- Campbell-McBride, N. Gut and Physiology Syndrome (2020), Cholesterol and nervous-system function.
- Ochoa-Repáraz, J., Kirby, T. O., and Kasper, L. H. (2018). The Gut Microbiome and Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine 8(6), a029017.
- Cekanaviciute, E., et al. (2017). Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. PNAS 114(40), 10713–10718.
- Hachim, M. Y., Elemam, N. M., and Maghazachi, A. A. (2019). The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis. Toxins 11(3), 147.
- Campbell-McBride, N. Official GAPS FAQs, Diseases and Symptoms, question 68.
- NINDS, Charcot-Marie-Tooth Disease, genetic types and peripheral-nerve involvement.
Leave a comment